Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma
Dilinaer Wusiman, Lei Guo, Zehao Huang, et al.
Pathology - Research and Practice (2022) Vol. 236, pp. 153934-153934
Open Access | Times Cited: 20

Showing 20 citing articles:

Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma
Sangeeta K. Bisheshar, Martine F. van der Kamp, Julius de Vries, et al.
Oral Oncology (2024) Vol. 153, pp. 106830-106830
Open Access | Times Cited: 3
Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis
Jina Choi, Nayoung Kim, Ryoung Hee Nam, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0282017-e0282017
Open Access | Times Cited: 7
Prognostic role of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: An institutional experience from India
Pooja Kala, Naveen Thapliyal, Bhawana Pant, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155133-155133
Closed Access | Times Cited: 2
Revisiting the Role of PD-L1 Overexpression in Prognosis and Clinicopathological Features in Patients with Oral Squamous Cell Carcinoma
Fernando Leporace-Jiménez, Isabel Portillo-Hernandez, Justino Jiménez‐Almonacid, et al.
Onco (2024) Vol. 4, Iss. 3, pp. 131-142
Open Access | Times Cited: 2
A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
Houyu Ju, Dongliang Wei, Yunteng Wu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 5
CD44, PDL1, and ATG7 Expression in Laryngeal Squamous Cell Carcinomas with Tissue Microarray (TMA) Technique: Evaluation of the Potential Prognostic and Predictive Roles
Lidia Puzzo, Maria Rita Bianco, Lucia Salvatorelli, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2461-2461
Open Access | Times Cited: 4
Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study
Dilinaer Wusiman, Lei Guo, Ling Li, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 1, pp. 91-100
Open Access | Times Cited: 4
Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma
Francis Proulx-Rocray, Denis Soulières
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 2, pp. 165-176
Closed Access | Times Cited: 1
Significance of PD-L1 and Tumor Microenvironment in Laryngeal Squamous Cell Cancer
Filip Tudor, Blažen Marijić, Emina Babarović, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2645-2645
Open Access | Times Cited: 1
Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms
Hyung-Gyo Cho, Soo Ick Cho, Sangjoon Choi, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2340-2340
Open Access | Times Cited: 6
Association of PD-L1 and p16 expression with clinicopathological parameters in oral cavity and oropharyngeal squamous cell carcinoma
Richa Kareer, Sana Ahuja, Neena Chaudhary, et al.
Pathology - Research and Practice (2022) Vol. 241, pp. 154266-154266
Closed Access | Times Cited: 6
Evaluation of Programmed Death - Ligand 1 (Pd-L1) Expression in Head and Neck Squamous Cell Carcinoma
Aarya Unnikrishnan, Vijaya Basavaraj
Iranian journal of pathology (2023) Vol. 18, Iss. 2, pp. 193-201
Open Access | Times Cited: 3
Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
Natalia Cichowska-Cwalińska, Michał Bieńkowski, Marta Popęda, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
High PD-L1 expression on immune cells along with increased density of tumor-infiltrating lymphocytes predicts a favorable survival outcome for patients with loco-regionally advanced head and neck cancer: early results from a prospective study
Tomáš Blažek, Marek Petráš, Pavel Hurník, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Immunohistochemical study of Programmed Cell Death Ligand 1 (PDL1) expression by combined positive score using 22C3 clone in head and neck squamous cell carcinomas, its correlation with clinicopathological features and outcome
Prithal Gangadhar, I Sandhya, Rachan Shetty, et al.
Journal of Oral and Maxillofacial Pathology (2024) Vol. 28, Iss. 1, pp. 29-36
Open Access
Combined Positive Score and Cisplatin Sensitivity Are Prognostic Factors for Response to Nivolumab Therapy for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
Hiroaki Iijima, Akihiro Sakai, Koji Ebisumoto, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma
Min Hee Hong, Se‐Hoon Lee, Thanh‐Trung Vo, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103961-103961
Open Access
Comprehensive analysis of single-cell and bulk RNA-sequencing data identifies B cell marker genes signature that predicts prognosis and analysis of immune checkpoints expression in head and neck squamous cell carcinoma
Dilinaer Wusiman, Wenbin Li, Lei Guo, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22656-e22656
Open Access | Times Cited: 1
Revisiting the Role of PD-L1 Overexpression in Prognosis and Clinicopathological Features in Patients with Oral Squamous Cell Carcinoma
Fernando Leporace-Jiménez, Isabel Portillo-Hernandez, Justino Jiménez‐Almonacid, et al.
(2023)
Open Access | Times Cited: 1
The dogma of cetuximab in advanced squamous cell carcinoma of the head and neck after failure of surgery and radiotherapy: is it true among patients in upper Egypt?
Amal Rayan, M Shahine, Khalid Rezk, et al.
ecancermedicalscience (2023) Vol. 17
Open Access
Page 1

Scroll to top